Answers are grounded in this paper and cite their sources.
The risk of malignant hyperthermia (MH) in patients with limb-girdle muscular dystrophy (LGMD) undergoing general anesthesia has attracted considerable attention; however, its clinical presentation is often atypical, leading to frequent missed diagnoses. In particular, intraoperative anesthetic management in genetically confirmed LGMD R9 (FKRP gene mutation) patients is rarely reported in the literature. Herein we report a case of a suspected MH-like hypermetabolic reaction, possibly representing an early or abortive presentation, although definitive confirmatory testing was not available, with abdominal muscle rigidity and clinically observed resistance to muscle relaxants during laparoscopic cholecystectomy in a patient with LGMD R9, and the subsequent successful management. We reported the case of a 27-year-old male with a genetically confirmed diagnosis of LGMD R9 (compound heterozygous FKRP mutations) who presented with acute suppurative cholecystitis and underwent laparoscopic cholecystectomy. Shortly after the establishment of pneumoperitoneum, the patient suddenly developed abdominal muscle rigidity. Despite the sequential administration of additional doses of mivacurium and rocuronium, the rigidity persisted, exhibiting a phenomenon of clinically observed resistance to muscle relaxants. However, vital signs, including end-tidal carbon dioxide partial pressure (PetCO2) and nasopharyngeal temperature, showed only mild fluctuations. Sevoflurane administration was immediately discontinued, and the anesthetic regimen was switched to total intravenous anesthesia (TIVA). Following this change, the muscle rigidity gradually resolved, and the surgical procedure was completed uneventfully. The patient recovered well postoperatively, with creatine kinase (CK) levels decreasing from a preoperative value of 2061 U/L to 907 U/L. He was discharged without any sequelae. Arterial blood gas analysis was not performed intraoperatively due to emergency conditions and limited access to point-of-care testing; however, the clinical constellation of findings provided sufficient grounds for clinical suspicion. For patients with LGMD, the occurrence of rigidity with clinically observed resistance to muscle relaxants during surgery, even in the absence of typical hyperthermia or severe acidosis - and even when confirmatory laboratory tests such as arterial blood gas analysis are unavailable - should raise a high index of suspicion for a suspected MH-like hypermetabolic reaction, possibly an early or atypical presentation of MH. The critical interventions are the immediate discontinuation of volatile anaesthetics and the switch to TIVA. This case provides a valuable reference for the perioperative anaesthetic management of patients with LGMD R9 and reinforces the importance of clinical vigilance in the absence of confirmatory testing.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: